[{"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - DrugsIntervention group: out of 300 patients, 150 patients with coronary artery from two medical centers (Rasoul Akram Hospital and Firoozgar Hospital) hydroxychloroquine phosphate treatment regimen 400 mg every 12 hours on the first day and then 200 mg every 12 hours for 5 to 7 Day + Sovodak (sofosbuvir + Daklatasvir) will be taken once a day (60/400 mg) for at least 5 to 7 days. Sovodak drug manufacturer is Faravan Rojan Mohaghegh Daroo (made in Iran) and chloroquine manufacturing company is Iran Daru (made in Iran).", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - DrugsIntervention group: out of 300 patients, 150 patients with coronary artery from two medical centers (Rasoul Akram Hospital and Firoozgar Hospital) Hydroxychloroquine phosphate treatment regimen 400 mg single dose + lupinavir / ritonavir combination 400/100 twice daily They will receive at least 5 days. The manufacturer of the drug is lupinavir / ritonavir (Kaletra), Gilead (made in Iran) and the manufacturer of chloroquine, Iran Daru (made in Iran).", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 1575, "treatment_name": "Daclatasvir+hydroxychloroquine+sofosbuvir", "treatment_type": "Antivirals+antimalarials", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 1562, "treatment_name": "Hydroxychloroquine+lopinavir+ritonavir", "treatment_type": "Antimalarials+antivirals", "pharmacological_treatment": "Pharmacological treatment"}]